Giiant Pharma Inc.
PrivateLast Round
Grant
Jan 10, 2023
Total Funding Raised
$12.51M
Company Overview
Giiant Pharma Inc. is a biotechnology company that develops gut-restricted, small molecule therapeutics for inflammatory bowel diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Giiant Pharma Inc. Comparables
Compare Giiant Pharma Inc. with similar companies based on industry and business-model similarity.
Giiant Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 10, 2023 | ||||
| Seed | Jun 30, 2021 | ||||
| Seed | May 21, 2021 |
Giiant Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Seed |
| Fonds de solidarité FTQ | Seed |
| Consortium Québécois sur la découverte du médicament | Seed |
| AQC Capital | Seed |
| Genesys Capital | Seed |
| Anges Quebec | Seed |
| Theodorus | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2021
$1M round led by AQC Capital and Consortium Québécois sur la découverte du médicament.
Giiant Pharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Giiant Pharma Inc.'s valuation, stock price, and market status.